Xalles Holdings Inc. (“Xalles”) (OTC: XALL), provides an update on recent share structure activities.
Since the start of the 4th Quarter, October 1, 2023 until January 18, 2024, there were restricted share conversions that resulted in 148,570,089 shares that were transitioned into unrestricted status. These shares included restricted shares previously purchased directly from the company, earned shares, and strategic notes.
Xalles also reports that since November 13th, 2023, XALL stock has seen substantial trading activity, with 330,348,469 shares traded. The approximately 330 million shares traded are from November 13, 2023, through to January 18, 2024, with November 13th being the first day that OTC Markets displayed the increase in unrestricted shares through data coming directly from the transfer agent.
Xalles continues to prioritize maximizing shareholder value, skillfully harmonizing the pursuit of revenue and profit opportunities with the strategic issuance of new shares.
About Xalles Holdings Inc. (OTC Pink: XALL)
Xalles Holdings Inc. is a leading holding company, specializing in innovative technology and financial service solutions. Focused on growth and diversification, Xalles Holdings is committed to developing cutting-edge technology-based solutions across various sectors, with an emphasis on supporting disruptive companies. Utilizing its proprietary Xalles RISE Business Model (Roll In, Selected Exit), the company actively seeks acquisition targets with solid management teams, robust business models, expansive total attainable markets (TAM), and enticing exit opportunities. Emphasizing the integration of blockchain and cutting-edge technologies, Xalles provides industry-leading solutions, poised to capture recurring revenue streams over time. Discover more at Xalles.com.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at SEC.gov and in OTC Markets at OTCMarkets.com.
Investor Relations Contact:
IR: 202.779.1460